Biotechnology
Shares of Fluoropharma Medical Inc Rally 37.5%
Shares of Fluoropharma Medical Inc. (OTCQB:FPMI) have risen a whopping 37.5% on the news that the company has acquired an exclusive option to license meta-Fluorobenzylguanidine (MFBG). MFBG is an imaging agent which has been acquired from ... [Read]
Biotechnology
MariMed Shares are Booming Despite Sideways Movement in the Marijuana Index
MariMed Inc (OTCQB:MRMD): MariMed shares are gaining positive momentum since the start of this year albeit sideways movement in the marijuana index. The North American marijuana index remains range-bound over the last two months after ... [Read]
Biotechnology
ObsEva SA Reaches Clinical Trial Endpoint – Shares Jump +25%
The Swiss-based biotechnology company ObsEva SA (NASDAQ:OBSV) has announced that it has reached the endpoints of its clinical trial with shares jumping over 25% after the announcement was made. The company, which focuses on developing ... [Read]
Biotechnology
Verastem Inc. Announces Stock Offering to Consonance Capital – Share Rise +15%
Massachusetts-based biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) announced on Thursday that it would be offering approximately seven million shares of the company’s common stock to Consonance Capital (private). Shares of the company rose over 15% on ... [Read]
Biotechnology
Galmed Pharmaceuticals Shares Surge Nearly 150% After Phase 2B Study
Shares of the Israeli biotechnology company Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) surged nearly 150% on Tuesday after the company released its results on the Phase 2B ARREST study. The study was meant to focus on the ... [Read]
Biotechnology
Vical Inc. Reports Failed Phase 2 Trial of Herpes Vaccine
California-based biotechnology company Vical Incorporated (NASDAQ:VICL) released, on Monday, the results of its Phase 2 herpes simplex virus-2 (HSV-2) therapeutic vaccine. Unfortunately, the trial failed to meet its primary endpoint, so the company has decided ... [Read]
Biotechnology
Axovant Sciences – Completes Company Reorganization for Pipeline Expansion
UK-based biotechnology company Axovant Sciences Ltd (NASDAQ:AXON) has completed the reorganization and strengthening of its management team in preparation for the company’s pipeline expansion. Axovant Sciences has announced that Gavin Corcoran will be joining the company as its ... [Read]
Biotechnology
ContraVir Pharmaceuticals Announces Reverse Stock Split
New Jersey-based biotechnology company ContraVir Pharmaceuticals (NASDAQ:CTRV) announced on Thursday that it will be having a reverse split of its common stock. A reverse stock split is meant to help a company to reduce “the ... [Read]
Biotechnology
Cara Therapeutics Enters into Agreement With Vifor Fresenius
Connecticut-based biotechnology company Cara Therapeutics (NASDAQ:CARA) has announced that it has entered into an agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. on Wednesday. Vifor Fresenius, a joint company from Vifor Pharma Group (SIX:VIFN) and ... [Read]
Biotechnology
BioDelivery Sciences International Announces Agreement with Broadfin Capital
Shares of the North Carolina-based biotechnology company BioDelivery Sciences International (NASDAQ:BDSI) jumped after the company announced that they had entered an agreement with Broadfin Capital LLC (private). The agreement is meant to help BioDelivery Sciences strengthen its ... [Read]